Doximity, Inc.
Company & revenue
About Doximity, Inc.
Who they are
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations.
Detailed revenue, brand and relationship research has not yet been completed for DOCS.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
55
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
83
Strong
Financial Strength
89
Business Quality / Moat
95
Management
100
Growth Quality
21
Risk / Durability
89
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
47
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
49/100
Building Historical Record
Model Score 49/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently rates the company as mixed to moderately strong.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •M&A headline · Sep 29, 2026
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for DOCS
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can DOCS maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is DOCS's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •How is DOCS likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What does the current fundamental change risk warning mean for the reliability or interpretation of DOCS's score?
Essential Investment Snapshot
Wall Street Score
55
Opportunity Score
47
Market Cap
$5.22B
P/E Ratio
31.8
EPS
$0.89
52-Week High
$74.33
52-Week Low
$17.15
Beta
1.25
Intrinsic Value
$34.27
Analyst Target
$25.50
Shares Outstanding
199.0M
Total Revenue
$655.6M
Total Debt
$9.7M
Dividend
No current dividend
Liquidation Value / Share
$4.60
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for DOCS
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
M&A headline · Sep 29, 2026
Shareholders who lost money in shares of acquired Doximity, Inc. (NYSE: DOCS) should contact Wolf Haldenstein Immediately — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
GlobeNewsWireCommunity Sentiment
0 active · 0 total callsNo personal call yet on DOCS.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 20.
- +Positive free cash flow may provide capacity to invest in growth.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
58
Sep 21, 2026
Change
-2.8
points
Current Score
55
Oct 1, 2026
Category Changes
DOCS decreased 2.8 points because Capital declined by 3 points, Valuation declined by 15.2 points.
Negative Contributors
- − Capital declined by 3 points
- − Valuation declined by 15.2 points
Projected Score
Projected Score
50
Projected Change
-5.6%
Preliminary comparable-period financial changes suggest decline of approximately 5.6 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$27.93
Intrinsic Value
$34.27
Difference
−$6.34
-18.5% vs IV
Margin of Safety
18.5%
Related Companies
Medical - Healthcare Information ServicesNews
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial